Key result
A history of stroke in patients with heart failure was associated with at least a 30% higher risk of fatal and non-fatal events and more than double the incidence of repeat stroke.
Why the study?
Stroke is an important comorbidity in HF, but little is known about the characteristics and outcomes of HF patients with a history of stroke across HFrEF and HFpEF.
Does a history of stroke increase the risk of adverse clinical outcomes in patients with heart failure?
Cohort (n=33,411)
Yes
Does a history of stroke increase the risk of adverse clinical outcomes in patients with heart failure?
A history of stroke is present in approximately 9% of heart failure patients and is associated with a significantly increased risk of fatal and non-fatal cardiovascular events, regardless of ejection fraction.
Flags HF patients with prior stroke for closer monitoring; leaves open whether targeted prevention improves outcomes.
Background Stroke is an important but neglected comorbidity in patients with heart failure (HF). Little is known about the characteristics and outcomes of HF patients with a history of stroke. Purpose To examine the prevalence of prior stroke in patients with HF and reduced ejection fraction (HFrEF) and HF with preserved ejection fraction (HFpEF), the clinical characteristics of patients with a history of stroke, and the clinical outcomes in patients with prior stroke compared to those without. Methods Individual patient data analysis using three recent HFrEF trials (ATMOSPHERE, PARADIGM-HF, and DAPA-HF) and HFpEF trials (CHARM-Preserved, I-Preserve, TOPCAT-Americas, and PARAGON-HF). Cox regression was used to analyze clinical outcomes. Results Among 20159 HFrEF patients enrolled, 1683 (8.3%) had a history of stroke and among the 13252 patients with HFpEF 1287 (9.7%) had a prior stroke. Compared to patients without stroke, those with stroke were slightly older and more likely to have a history of hypertension, myocardial infarction, atrial fibrillation, diabetes, carotid artery disease, and peripheral artery disease (for both HFrEF and HFpEF). Patients with a history of stroke had worse NYHA class and KCCQ scores, and a higher rate of fatigue; they also had a higher median NT-proBNP level and lower eGFR than those without prior stroke (whether HFrEF or HFpEF). Systolic BP, pulse pressure and LVEF did not differ susbtantialy between patients with and without a history of stroke. The table shows outcomes according to history of stroke or not, stratified by LVEF phenotype. During follow-up, all fatal and non-fatal outcomes were significantly more common in patients with a history of stroke. The augmentation of risk tended to be greater in patients with HFpEF than HFrEF, but was not statistically different. Conclusion Approximately 1 in 11 patients in recent HF trials had a history of stroke and these patients were at higher risk of fatal and non-fatal events than those without prior stroke. HF hospitalization as well as atherothrombotic events (myocardial infarction and stroke) were more common among patients with prior stroke – patients with prior stroke had at least 30% higher risk of all events examined, regardless of LVEF, and more than double incidence of repeat stroke. Funding Acknowledgement Type of funding sources: Other.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2022) conducted a cohort in Heart failure (n=33,411). History of stroke vs. No history of stroke was evaluated on Fatal and non-fatal events (including HF hospitalization, myocardial infarction, and stroke). A history of stroke in patients with heart failure was associated with at least a 30% higher risk of fatal and non-fatal events and more than double the incidence of repeat stroke.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: